Keyphrases
Alternative Regimens
22%
Antibody Concentration
11%
Capsular Polysaccharide
11%
Carrier Priming
11%
Chilean
11%
Conjugate Vaccine
22%
CRM197
33%
Developed Countries
11%
Diphtheria
11%
Diphtheria-tetanus-pertussis
11%
Dosing Regimen
100%
Economization
100%
Fractional Dose
100%
Haemophilus Influenzae Type b
100%
Haemophilus Influenzae Type b Vaccine
22%
Immunogenicity
100%
Oligosaccharides
11%
Phosphate Concentration
22%
Polyribosylribitol Phosphate
100%
Polysaccharide
11%
Protective Antibodies
11%
Randomized Trial
100%
Tetanus Toxoid
11%
Tetanus Vaccine
11%
Toxoid
11%
Two-dose
100%
Two-dose Schedule
11%
Vaccination
100%
Vaccination Schedule
11%
Pharmacology, Toxicology and Pharmaceutical Science
Conjugate Vaccine
60%
Diphtheria
40%
Diphtheria Pertussis Tetanus Vaccine
20%
Diphtheria Toxoid CRM197
60%
Haemophilus Influenzae Type B
100%
Haemophilus Influenzae Type B Vaccine
20%
Immunogenicity
100%
Oligosaccharide
20%
Pertussis
20%
Polysaccharide
40%
Tetanus
20%
Tetanus Toxoid
20%
Toxoid
20%
Vaccination Policy
100%
Immunology and Microbiology
Antibody Blood Level
20%
Conjugate Vaccine
60%
Diphtheria Toxoid CRM197
60%
DPT Vaccine
20%
Drug Dose Regimen
100%
Haemophilus Influenzae Type B
100%
Hib Vaccine
20%
Immunogenicity
100%
Tetanus Vaccine
20%
Toxoid
20%
Vaccination Policy
100%
Vaccination Schedule
20%